56
https://pubmed.ncbi.nlm.nih.gov/38117275
New synthetic compounds derived from a four-component Ugi reaction exhibit enhanced inhibition of α-glucosidase and α-amylase enzymes, potential targets for diabetes treatment, compared to the positive control acarbose, as shown by in vitro and in silico evaluations.